Mercedes Fernández-Lobato
Grupo de investigación
- Control traduccional de la enfermedad hepática y el cáncer Group leader (R4)
Publicaciones destacadas
-
Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development
Autores:Referencia: Iscience 2022. -
Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis
Autores:Referencia: Molecular Metabolism 2021. -
Metabolic Reprogramming of Liver Fibrosis
Autores:Referencia: Cells 2021. -
Identification of dynamic RNA-binding proteins uncovers a Cpeb4-controlled regulatory cascade during pathological cell growth of cardiomyocytes
Autores:Referencia: Cell Reports 2021. -
CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis
Autores:Referencia: Gastroenterology 2020. -
Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension
Autores:Referencia: Gut 2017. -
Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress
Autores:Referencia: Nature Cell Biology 2017. -
Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease
Autores:Referencia: Gastroenterology 2016. -
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats
Autores:Referencia: Gut 2015. -
Disruption of negative feedback loop between vasohibin-1 and VEGF decreases portal pressure, angiogenesis and fibrosis in cirrhotic rats
Autores:Referencia: Hepatology 2014.